Open | $22.130 |
Close | $22.330 |
Volume / Avg. | 523.344K / 814.277K |
Day Range | 21.250 - 22.609 |
52 Wk Range | 11.830 - 28.800 |
Market Cap | $1.094B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 10.7% |
Days to Cover | 4.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regenxbio (NASDAQ: RGNX) through any online brokerage.
Other companies in Regenxbio’s space includes: Macrogenics (NASDAQ:MGNX), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL), Centessa Pharmaceuticals (NASDAQ:CNTA) and Immatics (NASDAQ:IMTX).
The latest price target for Regenxbio (NASDAQ: RGNX) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 36.00 expecting RGNX to rise to within 12 months (a possible 61.22% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Regenxbio (NASDAQ: RGNX) is $22.33 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Regenxbio.
Regenxbio’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Regenxbio.
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.